HYFT
MindWalk Holdings Corp.
HYFT offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NVO
Novo Nordisk A/S
NVO has the edge over HYFT overall, supported by lower modeled downside and stronger fundamentals.
HYFT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
HYFT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HYFT PE Valuation
HYFT has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
HYFT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HYFT's losses to grow, with revenue growing.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
NVO has the edge over HYFT on the outlook, with more favorable earnings expectations.
HYFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$0.75 | -$0.34 |
| Q2 2022 | -$0.60 | -$0.29 |
| Q1 2022 | -$0.65 | -$0.50 |
| Q4 2021 | -$0.57 | -$0.44 |
| Q3 2021 | -$0.41 | -$0.23 |
| Q2 2021 | -$0.31 | -$0.05 |
| Q1 2021 | -$0.15 | +$0.26 |
| Q4 2020 | -$0.13 | +$0.31 |
NVO has the stronger earnings trend. Trailing diluted EPS is down 135% for HYFT versus NVO up 4.9%.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO's earnings per share have climbed steadily: $3.89 over the past year, up 4.9% from the year before, and higher year over year every quarter since late 2020.
HYFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +23% |
| Q2 2026 | $2.9M | -42% |
| Q1 2026 | $2.9M | -32% |
| Q4 2025 | $2.9M | -33% |
| Q3 2025 | $2.2M | -40% |
| Q2 2025 | $4.9M | +8.1% |
| Q1 2025 | $4.3M | -1.1% |
| Q4 2024 | $4.3M | -0.4% |
HYFT's revenue is recovering but still below its 2025 peak: $3M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -160% | -28 points |
| Q2 2026 | -105% | -78 points |
| Q1 2026 | -95% | +304 points |
| Q4 2025 | -77% | -28 points |
| Q3 2025 | -132% | -42 points |
| Q2 2025 | -27% | +264 points |
| Q1 2025 | -399% | -343 points |
| Q4 2024 | -50% | -16 points |
HYFT's operating margin was −160% last quarter, down 28 points from the same quarter a year ago.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over HYFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over HYFT on profitability, with a higher operating margin.
HYFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.9M | +$218.3K |
| Q2 2026 | -$1.8M | -$719.4K |
| Q1 2026 | -$2.1M | -$1.2M |
| Q4 2025 | -$2.1M | -$447.1K |
| Q3 2025 | -$3.2M | -$1.7M |
| Q2 2025 | -$1.1M | +$1.6M |
| Q1 2025 | -$924.5K | -$572.3K |
| Q4 2024 | -$1.6M | -$1.4M |
HYFT has burned cash in almost every quarter: −$9M over the past year, against −$7M the year before.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over HYFT on cash generation, producing positive trailing cash flow while its opponent burns cash.
HYFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +95.2K shares |
| 1 year | +1.4% | +653K shares |
| 3 years | +87% | +21.8M shares |
| 5 years | +177% | +29.9M shares |
| Available history | +244% | +33.2M shares |
HYFT has 47M diluted shares, up 1.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over HYFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
HYFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | -7.4x | Net Cash |
| Q4 2020 | -5.5x | Net Cash |
| Q3 2020 | -0.8x | Net Cash |
HYFT has more cash than debt.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
HYFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 8.2 | Oversold |
HYFT's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
HYFT PE vs Healthcare Sector
HYFT has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HYFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.23 | 19% below |
| 20 week MA | $1.32 | 24% below |
| 50 week MA | $1.45 | 31% below |
| 100 week MA | $1.28 | 22% below |
| 200 week MA | $1.56 | 36% below |
HYFT is in a downtrend: it's below all five of its weekly moving averages, and 36% below its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over HYFT on trend strength, trading above more of its moving averages.
HYFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.20 | $16.4 | +645% |
| 2021 | $16.4 | $5.36 | -67% |
| 2022 | $5.36 | $5.72 | +6.7% |
| 2023 | $5.72 | $1.71 | -70% |
| 2024 | $1.71 | $0.41 | -76% |
| 2025 | $0.41 | $1.70 | +315% |
| 2026 YTD | $1.70 | $1.00 | -41% |
HYFT's yearly returns have swung widely, from +645% in 2020 to −76% in 2024. It's down 41% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over HYFT on returns for 2026, with the stronger performance.